Federated Hermes, Inc. Abb Vie Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,869,279 shares of ABBV stock, worth $333 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

1,869,279

Previous 1,820,521 2.68%

Holding current value

$333 Million

Previous $312 Million 18.22%

% of portfolio

0.85%

Previous 0.76%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $7.99 Million - $9.72 Million	48,758 Added 2.68%	1,869,279 $369 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $5.06 Million - $5.91 Million	32,708 Added 1.83%	1,820,521 $312 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $80.7 Million - $91.9 Million	-504,840 Reduced 22.02%	1,787,813 $326 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $60.2 Million - $67.8 Million	437,672 Added 23.59%	2,292,653 $355 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $1.69 Million - $1.96 Million	12,663 Added 0.69%	1,854,981 $277 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $104 Million - $129 Million	-784,659 Reduced 29.87%	1,842,318 $248 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $4.21 Million - $4.85 Million	-29,143 Reduced 1.1%	2,626,977 $419 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $31.6 Million - $37.8 Million	228,140 Added 9.4%	2,656,120 $430 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $24.7 Million - $28.3 Million	-183,878 Reduced 7.04%	2,427,980 $326 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $177 Million - $226 Million	-1,289,081 Reduced 33.05%	2,611,858 $400 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $167 Million - $207 Million	-1,264,452 Reduced 24.48%	3,900,939 $632 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $12.7 Million - $16 Million	117,783 Added 2.33%	5,165,391 $699 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $352,077 - $399,661	-3,309 Reduced 0.07%	5,047,608 $544 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $8.6 Million - $9.58 Million	-81,755 Reduced 1.59%	5,050,917 $569 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $5.58 Million - $6.14 Million	-54,512 Reduced 1.05%	5,132,672 $555 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $32.7 Million - $44.1 Million	-405,822 Reduced 7.26%	5,187,184 $556 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $83.6 Million - $98.2 Million	-973,543 Reduced 14.83%	5,593,006 $490 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $117 Million - $157 Million	-1,596,712 Reduced 19.56%	6,566,549 $645 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $18.9 Million - $28.7 Million	-293,090 Reduced 3.47%	8,163,261 $622 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $11.1 Million - $13.9 Million	-154,167 Reduced 1.79%	8,456,351 $749 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $39.8 Million - $47.8 Million	631,857 Added 7.92%	8,610,518 $652 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $1.16 Million - $1.48 Million	-17,629 Reduced 0.22%	7,978,661 $580 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $125 Million - $147 Million	1,623,690 Added 25.48%	7,996,290 $644 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $210 Million - $260 Million	2,702,968 Added 73.66%	6,372,600 $587 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $131 Million - $145 Million	1,469,718 Added 66.81%	3,669,632 $347 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $55.7 Million - $66 Million	-620,922 Reduced 22.01%	2,199,914 $204 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $311 Million - $416 Million	-3,377,602 Reduced 54.49%	2,820,836 $267 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $397 Million - $436 Million	-4,437,598 Reduced 41.72%	6,198,438 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $743 Million - $949 Million	10,636,036	10,636,036 $945 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Abb Vie Inc. Transaction History